Related Experiment Videos

Ongoing risk stratification trials: the primary prevention of sudden death

¹Department of Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA.

Controlled Clinical Trials

|June 1, 1996

Abstract:

This paper reviews three ongoing risk stratification trials: the Coronary Artery Bypass Grafting-Patch Trial (CABG-Patch), the Multicenter Automatic Implantable Defibrillator Trial (MADIT), and the Multicenter Unsustained Tachycardia Trial (MUSTT).

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Bradycardic syncope in 2 patients who recently began gatifloxacin treatment.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2003

Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: clinical and trial design implications.

Journal of the American College of Cardiology·2001

Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysis.

Journal of the American College of Cardiology·2001

Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction.

Circulation·2001

Current approaches to evaluation and management of patients with ventricular arrhythmias.

Medicine and health, Rhode Island·2001

Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function. MUSTT Investigators. Multicenter UnSustained Tachycardia Trial.

The American journal of cardiology·2001

See all related articles